Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report
Journal of Contemporary Brachytherapy · 2026
DOI: 10.5114/jcb.2026.165785 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Contemporary Brachytherapy, 2026. Verfasst von Leona Marie Francesca Rebosa und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report Leona Marie Francesca S. Rebosa 1 , Eugene Richard T. Yap 1 , Stellar Marie R. Cabrera 1 , Maureen R. Bojador 1 , Vannesza Hendricke C. Chua 1 , Patricia J. Ong 1 , Bryce Matthew L. Tan de Guzman 1 , Warren R. Bacorro 1, 2 Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines Department of Clinical Epidemiology, University of Santo Tomas, Faculty of Medicine and Surgery, Manila, Philippines J Contemp Brachytherapy 2026 DOI: https://doi.org/10.5114/jcb.2026.165785 Online publish date: 2026/10/20 View full text Get citation Get citation ENW EndNote BIB JabRef, Mendeley RIS Papers, Reference Manager, RefWorks, Zotero AMA Rebosa LS, Yap ET, Cabrera SR, et al. Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165785. APA Rebosa, L. S., Yap, E. T., Cabrera, S. R., Bojador, M., Chua, V. C., & Ong, P. J. et al. (2026). Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165785 Chicago Rebosa, Leona Marie Francesca S, Eugene Richard T Yap, Stellar Marie R Cabrera, Maureen R. Bojador, Vannesza Hendricke C Chua, Patricia J Ong, and Bryce Matthew L Tan de Guzman et al. 2026. "Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report". Journal of Contemporary Brachytherapy. doi:10.5114/jcb.2026.165785. Harvard Rebosa, L., Yap, E., Cabrera, S., Bojador, M., Chua, V., Ong, P., Tan de Guzman, B., and Bacorro, W. (2026). Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165785 MLA Rebosa, Leona Marie Francesca et al. "Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report." Journal of Contemporary Brachytherapy, 2026. doi:10.5114/jcb.2026.165785. Vancouver Rebosa L, Yap E, Cabrera S, Bojador M, Chua V, Ong P et al. Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165785. IntroductionTo report the efficacy and safety of high-dose-rate (HDR) plesiotherapy using a customized applicator for sebaceous carcinoma of the eyelid in a patient with contraindications to interstitial brachytherapy. Material and methodsA 84-year-old female, ECOG 0, was diagnosed with localized sebaceous gland carcinoma (SGC; stage IB, T2aN0M0), of the left upper eyelid. The patient was not cleared for surgery or interstitial brachytherapy; HDR plesiotherapy was given as 14 fractions 3.5 Gy per fraction, twice daily, over 11 days, with a three-day break after seven fractions. Surface mold applicator was created using a thermoplastic mask, and plastic catheters were secured with dental putty over the mask; the mask served as both a bolus and spacer. High-risk clinical target volume (HR-CTV) comprised the tumor and involved lateral canthus, while intermediate-risk clinical target volume (IR-CTV) consisted of 5 mm around HR-CTV. Eyelid scarring excluded corneal shielding. Due to pre-existing cataract, a higher left lens dose allowed delivery of definitive doses. ResultsHR-CTV D90, IR-CTV D95, lens D0.1cc, and cornea D0.1cc were 3.74 Gy, 2.66 Gy, 1.81 Gy, and 3.23 Gy, respectively, resulting in EQD2 (α/β = 10 for tumor, α/β = 3 for normal tissue; no interfraction repair for tumor assumed) of 73.9 Gy, 46.4 Gy, 24.4 Gy, and 56.3 Gy, respectively. According to the patient’s preference, no elective neck management was performed. The patient developed only acute grade 2 blepharitis and conjunctivitis, with no signs of radiation keratitis. At 2-year follow-up, she developed an ipsilateral neck recurrence, which was otherwise asymptomatic. No salvage or palliative treatment was administered. No late radiation-induced toxicity was documented. At five years, local control was maintained. ConclusionsThis case demonstrates that HDR plesiotherapy is a feasible option for local control of the eyelid SGC with a favorable toxicity profile, even when corneal shielding is not possible. Keywords sebaceous gland carcinoma, eyelid, plesiotherapy
Zitieren
APA
Rebosa, L. M. F., Yap, E. R., Cabrera, S. M., Bojador, M. R., Chua, V. H., Ong, P., Guzman, B. M. T. D., & Bacorro, W. R. (2026). Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2026.165785
Vancouver
Rebosa LMF, Yap ER, Cabrera SM, Bojador MR, Chua VH, Ong P, et al. Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report. Journal of Contemporary Brachytherapy. 2026. doi:10.5114/jcb.2026.165785
BibTeX
@article{Rebosa2026,
author = {Rebosa, Leona Marie Francesca and Yap, Eugene Richard and Cabrera, Stellar Marie and Bojador, Maureen R. and Chua, Vannesza Hendricke and Ong, Patricia and Guzman, Bryce Matthew Tan de and Bacorro, Warren R.},
title = {Long-term outcomes of high-dose-rate plesiotherapy for sebaceous gland carcinoma (SGC) of the eyelid: A case report},
journal = {Journal of Contemporary Brachytherapy},
year = {2026},
doi = {10.5114/jcb.2026.165785}
}
EUVIMED